What I do at MMV:
My role as clinical scientist is to design clinical trials, including drafting relevant trial documents, as well as the analysis and interpretation of data for the development of new, effective, and affordable antimalarial medicines.
Why I work at MMV:
I feel privileged to work for a non profit organization with the noble mission of reducing the burden of a disease affecting vulnerable and impoverished populations. Being surrounded by colleagues who share the same passion and commitment is both rewarding and motivating in and of itself.
More about me:
I hold a Doctor of Pharmacy degree and obtained my PhD from the University Hospital of Lausanne, Switzerland, with the main objective of developing and expanding therapeutic drug monitoring of anticancer agents. Through this endeavour, I gained knowledge in clinical research, pharmacokinetics and bioanalysis. Subsequently, I undertook a postdoc at the University of Geneva in collaboration with MMV. These first steps in the field of malaria research sparked my further interest in developing drugs for unmet medical needs. In 2014, I moved to the pharmaceutical industry at Debiopharm in the clinical pharmacology and drug metabolism group where I expanded my knowledge of drug development and clinical pharmacology.
Ask me about:
Drug development, clinical pharmacology. Outside of science, I really enjoy meeting people and discovering new cultures. If you don’t find me at MMV, I’m probably meditating alongside the lake.